C4 glomerulopathy causes

	C4 glomerulopathy Microchapters
Complement Mediated Glomerular Disorders Main Page
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating C4 glomerulopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Studies
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
C4 glomerulopathy causes On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of C4 glomerulopathy causes All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on C4 glomerulopathy causes
CDC on C4 glomerulopathy causes
C4 glomerulopathy causes in the news
Blogs on C4 glomerulopathy causes
Directions to Hospitals Treating C4 glomerulopathy
Risk calculators and risk factors for C4 glomerulopathy causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]

Overview

Common causes of is not yet known but C4 glomerulopathy is analogous to C3 glomerulopathy and the causes may include^[1]^[2]^[3]^[4]^[5]:

C4 Nephritic factor-an autoantibody against C4 can cause complement dysregulation against immune complex-myeloproliferative glomerulonephritic patients.
Mutation of complement factor H (CFH).
- CFH is a small glycoprotein that is produced in the liver and circulates freely in the blood plasma.
- Autoantibodies against CFH.
Anti-Factor H, anti-Factor B, and C3- or C4 nephritic factors are frequently seen in patients with complement-mediated renal disorders.
Mutation of membrane cofactor protein (MCP).

↑ Rodríguez de Córdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sánchez-Corral P (June 2004). "The human complement factor H: functional roles, genetic variations and disease associations". Mol. Immunol. 41 (4): 355–67. doi:10.1016/j.molimm.2004.02.005. PMID 15163532.
↑ Noris M, Donadelli R, Remuzzi G (June 2018). "Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy". Pediatr. Nephrol. doi:10.1007/s00467-018-3989-0. PMID 29948306.
↑ Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J; et al. (2017). "Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN". J Am Soc Nephrol. 28 (5): 1603–1613. doi:10.1681/ASN.2016030343. PMC 5407719. PMID 28096309.
↑ Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G; et al. (2017). "C4 Nephritic Factors in C3 Glomerulopathy: A Case Series". Am J Kidney Dis. 70 (6): 834–843. doi:10.1053/j.ajkd.2017.07.004. PMC 5701858. PMID 28838767.
↑ Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M; et al. (2015). "Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases". J Immunol. 194 (11): 5129–38. doi:10.4049/jimmunol.1402770. PMID 25917093.